Products Open For Subscription:

  • Ireland Accelerated Tracker
  • Europe Accelerated Tracker
  • Emerging Markets Delta 1 Certificate
  • Gold Bullion Delta 1 Certificate

To find out more click on the access RBS platform button below:

Quick Links:

Listed Products 


Our team, through RBS, are delighted to bring Listed Products to the Irish market. These products, provided by RBS, deliver exposure to major world indices, equity, commodity and rate markets. Access your investment when you need to and enjoy transparent pricing on the London Stock Exchange. Buy and sell investment products simply through your normal stockbroker.

The purchase of these products may entail risks. In particular, changes in interest and exchange rates, the credit of an issuer of a security and the political climate may have a negative effect on the value, price or return of the securities and financial instruments.

Your capital is at risk if the Listed Product or investment strategy does not perform as expected. You could lose some or all of your money. The value of all Listed Products may fall as well as rise and the price which you receive may be less than your original investment. These products may not be suitable for all investors, you should therefore ensure you fully understand the risks involved and seek independent advice where necessary. In the event that RBS becomes insolvent, your investment would be at risk and you could lose some or all of your investment.



Ulster Bank Ireland Limited. A private company limited by shares, trading as Ulster Bank, Ulster Bank Group and Banc Uladh. Registered in Republic of Ireland. Registration Number 25766. Registered Office: Ulster Bank Group Centre, George’s Quay, Dublin 2. Ulster Bank Ireland Limited is regulated by the Central Bank of Ireland. Calls may be recorded. This document is an advertisement and not a prospectus for the purposes of EU directive 2003/71/EC (the “Directive”) and any implementing legislation. A prospectus has been prepared and made available to the public in accordance with the Directive. Investors should not subscribe for any securities referred to in this document except on the basis of information contained in the prospectus. Investors may obtain copies of the prospectus from the offices of the issuer and the paying agents.

Best in Ireland Awards